|
⚲
|
| Keyboard |
| Sabba Stephen L
✚
|
|
|---|---|
| CIK # | 0001442372 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001442372] | |
| 4 | [0001442372] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sabba Stephen L | |
| Ligand Pharmaceuticals Inc | |
| Novelion Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-23 | Sell | 1,000 | $207.87 | 207,870 |
|
Ligand Pharmaceuticals Inc LGND
Non- Qualified Stock Option (right to buy) · derivative
|
2026-03-03 | Option exercise | 2,034 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-03 | Option exercise | 2,034 | $69.51 | 141,383 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-03 | Sell | 2,034 | $201.50 | 409,851 |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-06 | Grant | 5,783 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-06-06 | Grant | 1,209 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2025-04-01 | Option exercise | 2,406 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-04-01 | Option exercise | 2,406 | $52.30 | 125,834 |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2024-06-14 | Grant | 5,444 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-06-14 | Grant | 1,252 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2024-03-05 | Option exercise | 2,893 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-03-05 | Sell | 1,893 | $74.30 | 140,650 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-03-05 | Option exercise | 2,893 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2023-06-09 | Grant | 1,142 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2023-06-09 | Grant | 5,461 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2023-05-10 | Sell | 6,408 | $77.13 | 494,249 |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2023-05-10 | Option exercise | 6,408 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2023-05-10 | Option exercise | 6,408 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2022-12-22 | Grant | 6,623 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Non-Qualified Stock Option (right to buy) · derivative
|
2022-06-10 | Grant | 4,340 | $0.00 | |
| showing 20 of 76 most recent transactions | |||||